No Picture
Trading Ideas

Nasdaq's China Crackdown Looks Halfhearted

(Bloomberg Opinion) — Nasdaq is tightening rules on initial public offerings in an effort that looks to be targeted primarily at Chinese companies. To appreciate just how tepid its proposals are, consider this: They wouldn’t have screened out Luckin Coffee Inc., the most notorious accounting scandal involving a U.S.-listed Chinese issuer in years. On this evidence, IPO hopefuls have little to worry about — as long as they’re not too small.Companies will need to raise at least $25 million, or sell stock equal to a minimum 25% of their post-listing market capitalization, according to a Bloomberg News report that cited …read more […]

No Picture
Trading Ideas

Cisco’s Results Disappoint, Revealing a Challenging April

High-tech stalwart Cisco Systems (CSCO) was one of the first major companies to report results for the fiscal quarter that ended in April. The results posted Wednesday afternoon are more reflective of the impact of Covid-19 than those in other recent earnings calls which only reflected results through March. And the results were grim: Cisco’s revenue for its fiscal third quarter fell 8% year-over-year to about $12 billion, its worst decline in six years. And yet, its per-share adjusted earnings of 79 cents on revenue of $11.98B easily beat analysts’ bleak target of 71 cents. The service and security segments …read more […]

No Picture
Trading Ideas

Johnson & Johnson To Discontinue Talc-Based Baby Powder in US and Canada

Johnson & Johnson (JNJ) has decided to permanently discontinue talc-based Johnson’s Baby Powder in both the US and Canada, citing declining demand and misinformation.“Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising” JNJ said.However, Johnson & Johnson remains confident in the safety of talc-based Johnson’s Baby Powder. “Decades of scientific studies by medical experts around the world support the safety of our product” argued the healthcare giant, adding that it will …read more […]